IRIS Accounts Production v23.3.1.45 SC595281 Board of Directors 1.5.22 30.4.23 30.4.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC5952812022-04-30SC5952812023-04-30SC5952812022-05-012023-04-30SC5952812021-04-30SC5952812021-05-012022-04-30SC5952812022-04-30SC595281ns10:Originalns15:Scotland2022-05-012023-04-30SC595281ns14:PoundSterlingns10:Original2022-05-012023-04-30SC595281ns10:Originalns10:Director12022-05-012023-04-30SC595281ns10:Original2022-05-012023-04-30SC595281ns10:Original2023-04-30SC595281ns10:Originalns10:PrivateLimitedCompanyLtd2022-05-012023-04-30SC595281ns10:Originalns10:SmallEntities2022-05-012023-04-30SC595281ns10:Originalns10:AuditExempt-NoAccountantsReport2022-05-012023-04-30SC595281ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-05-012023-04-30SC595281ns10:SmallCompaniesRegimeForAccountsns10:Original2022-05-012023-04-30SC595281ns10:Originalns10:FullAccounts2022-05-012023-04-30SC595281ns10:Originalns10:Director22022-05-012023-04-30SC595281ns10:Originalns10:RegisteredOffice2022-05-012023-04-30SC595281ns10:Original2022-04-30SC595281ns10:Originalns5:CurrentFinancialInstruments2023-04-30SC595281ns10:Originalns5:CurrentFinancialInstruments2022-04-30SC595281ns10:Originalns5:Non-currentFinancialInstruments2023-04-30SC595281ns10:Originalns5:Non-currentFinancialInstruments2022-04-30SC595281ns5:ShareCapitalns10:Original2023-04-30SC595281ns5:ShareCapitalns10:Original2022-04-30SC595281ns10:Originalns5:SharePremium2023-04-30SC595281ns10:Originalns5:SharePremium2022-04-30SC595281ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-04-30SC595281ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-04-30SC595281ns10:Original2021-05-012022-04-30SC595281ns10:Originalns5:PlantMachinery2022-04-30SC595281ns10:Originalns5:PlantMachinery2022-05-012023-04-30SC595281ns10:Originalns5:PlantMachinery2023-04-30SC595281ns10:Originalns5:PlantMachinery2022-04-30SC595281ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-30SC595281ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-04-30
REGISTERED NUMBER: SC595281 (Scotland)
















Unaudited Financial Statements

for the Year Ended 30th April 2023

for

Tayside Complete Health Limited

Tayside Complete Health Limited (Registered number: SC595281)






Contents of the Financial Statements
for the Year Ended 30th April 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Tayside Complete Health Limited

Company Information
for the Year Ended 30th April 2023







DIRECTORS: M Groome
M C Barron





REGISTERED OFFICE: 7 Commercial Street
Dundee
Angus
DD1 3DA





REGISTERED NUMBER: SC595281 (Scotland)





ACCOUNTANTS: Sigma Partners
Delmon House
36-38 Church Road
Burgess Hill
West Sussex
RH15 9AE

Tayside Complete Health Limited (Registered number: SC595281)

Balance Sheet
30th April 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 63,312 70,910

CURRENT ASSETS
Debtors 5 57,916 38,550
Cash at bank and in hand 59,954 69,725
117,870 108,275
CREDITORS
Amounts falling due within one year 6 155,349 155,454
NET CURRENT LIABILITIES (37,479 ) (47,179 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

25,833

23,731

CREDITORS
Amounts falling due after more than one
year

7

(21,797

)

(31,790

)

PROVISIONS FOR LIABILITIES (106 ) (13,367 )
NET ASSETS/(LIABILITIES) 3,930 (21,426 )

CAPITAL AND RESERVES
Called up share capital 7 7
Share premium 49,993 49,993
Retained earnings (46,070 ) (71,426 )
3,930 (21,426 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Tayside Complete Health Limited (Registered number: SC595281)

Balance Sheet - continued
30th April 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17th January 2024 and were signed on its behalf by:





M Groome - Director


Tayside Complete Health Limited (Registered number: SC595281)

Notes to the Financial Statements
for the Year Ended 30th April 2023

1. STATUTORY INFORMATION

Tayside Complete Health Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2022 - 15 ) .

Tayside Complete Health Limited (Registered number: SC595281)

Notes to the Financial Statements - continued
for the Year Ended 30th April 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st May 2022 136,585
Additions 5,790
At 30th April 2023 142,375
DEPRECIATION
At 1st May 2022 65,675
Charge for year 13,388
At 30th April 2023 79,063
NET BOOK VALUE
At 30th April 2023 63,312
At 30th April 2022 70,910

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 52,433 35,975
Other debtors 5,483 2,575
57,916 38,550

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 9,773 9,506
Trade creditors 117,143 102,339
Taxation and social security 11,547 3,313
Other creditors 16,886 40,296
155,349 155,454

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
2023 2022
£    £   
Bank loans 21,797 31,790

Tayside Complete Health Limited (Registered number: SC595281)

Notes to the Financial Statements - continued
for the Year Ended 30th April 2023

8. RELATED PARTY DISCLOSURES

All of the administration charges are paid to Complete Health Group Limited, a company in which the directors are also directors and shareholders.

Such transactions are considered to be at arms length.